Nephrology
From the Journals
Biomarkers predict cardiovascular risk in chronic kidney disease patients
New models to stratify atherosclerotic cardiovascular disease risk may improve shared decision-making.
Latest News
No COVID vax, no transplant: Unfair or good medicine?
Is removing them from the list unfair and cruel, or simply business as usual?
From the Journals
Allopurinol found safe in patients with concomitant gout, CKD
Despite earlier concerns, a study has found no sign of increased mortality with allopurinol therapy in patients with gout and chronic kidney...
From the Journals
HIV+ patients get good outcomes after kidney or liver transplant
New research further supports the inclusion of people with HIV in transplant resource allocation.
Conference Coverage
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
Conference Coverage
ADVOCATE: Avacopan shows renal benefits in ANCA vasculitis
A subanalysis of renal effects in the phase 3 ADVOCATE trial found that avacopan improved estimated glomerular filtration rate best among patients...
Conference Coverage
Oral daprodustat safely improves anemia in chronic kidney disease
“What’s out there [for daprodustat] seems very encouraging,” according to a nephrologist.
Conference Coverage
Finerenone, sotagliflozin exert heart failure benefits despite renal dysfunction
Secondary trial analyses in patients with type 2 diabetes showed both finerenone and sotagliflozin had heart failure benefits across the spectrum...
From the Journals
SGLT2 inhibitors for diabetes: No link to fractures in older adults
Analysis of Medicare data supports findings from younger adults that use of the drug class does not appear to raise fracture risk.
Conference Coverage
Real-world data favor invasive strategy for NSTEMI with CKD
The clinical benefits of initial invasive management came with a “minimal increased risk” of in-hospital acute kidney injury and major bleeding in...
From the Journals
Fluoroquinolones linked to sudden death risk for those on hemodialysis
Most patients undergoing hemodialysis have a least one risk factor for drug-induced QT interval prolongation.